TuHURA Biosciences
HURA
9 hedge funds and large institutions have $181K invested in TuHURA Biosciences in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.03% less ownership
Funds ownership: 0.12% → 0.09% (-0.03%)
10% less funds holding
Funds holding: 10 → 9 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
61% less capital invested
Capital invested by funds: $464K → $181K (-$283K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$58.9K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.75K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$4.05K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$193 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$102K |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$82K |
| 3 |
LC
Lindbrook Capital
Calabasas,
California
|
-$14.7K |
| 4 |
Morgan Stanley
New York
|
-$4.82K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$579 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $51.7K | -$579 | -3 | -0.7% |
|
2
State Street
Boston,
Massachusetts
| $39.5K | – | – | – |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $39.2K | +$58.9K | +305 | New |
|
4
Acadian Asset Management
Boston,
Massachusetts
| $22K | – | – | – |
|
|
5
Morgan Stanley
New York
| $11.8K | -$4.82K | -25 | -21% |
|
|
6
UBS Group
Zurich,
Switzerland
| $7.55K | +$4.05K | +21 | +53% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $6K | +$6.75K | +35 | +219% |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $3.45K | – | – | – |
|
|
9
Fidelity Investments
Boston,
Massachusetts
| $107 | +$193 | +1 | New |
|
10
Wells Fargo
San Francisco,
California
| $39 | – | – | – |
|
|
11
Vanguard Group
Malvern,
Pennsylvania
| – | -$102K | -424 | Closed |
|
|
NCM
12
Nantahala Capital Management
New Canaan,
Connecticut
| – | -$82K | -340 | Closed |
|
|
LC
13
Lindbrook Capital
Calabasas,
California
| – | -$14.7K | -61 | Closed |
|
14
Bank of America
Charlotte,
North Carolina
| – | -$7 | – | – |
|
HURA Hedge Fund Activity: Q1 2023 in Review
9 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q1 2023, worth a combined $181K — down 61% from $464K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of HURA and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $58.9K. The largest seller was Vanguard Group, exiting entirely with an estimated $102K sold.
- 9 institutional investors held TuHURA Biosciences (HURA) as of Q1 2023, down from 10 in Q4 2022.
- Funds reported $181K of TuHURA Biosciences stock for Q1 2023, down 61% quarter-over-quarter.
- 2 funds opened new TuHURA Biosciences positions in Q1 2023 and 3 closed out, a net change of -1 holder.
- The largest TuHURA Biosciences buyer in Q1 2023 was Susquehanna International Group, an estimated $58.9K added.
- The largest TuHURA Biosciences seller in Q1 2023 was Vanguard Group, an estimated $102K sold.
Based on aggregated 13F filings for Q1 2023.